Friday, March 19, 2010: 4:00 PM-6:00 PM
Centennial III-IV (Hyatt Regency Atlanta)
CME Credits: 2
Summary: Great progress has been made in the prevention of device-associated infections. However, as pressure to eliminate these infections intensifies, there will be increased focus on the addition of prevention approaches that have not yet been included in a “bundled” approach. This session will assist infection preventionists in applying evidence based prevention measures and in selecting the most promising new approaches to prevention of device-associated infections.Learning Objectives:
- Identify new technologies related to intubation and body positioning and assess evidence supporting appropriate use to prevent VAP.
- Review advantages and disadvantages to routine use of topical and nebulized antimicrobial prophylaxis or chlorhexidine in the prevention of VAP.
- Review progress in prevention of catheter-associated bloodstream infections, and identify potential new approaches to prevention (e.g. antimicrobial locks, new catheter technology).
- Apply evidence-based prevention measures for catheter-associated urinary tract infections (CAUTIs), and review new CAUTI prevention guidelines.
- Assess the need for “bundled” interventions, and understand how the individual bundle components might be selected for inclusion or exclusion.
C. Glen Mayhall, MD and David K. Warren, MD